- #544 Ramprakash V Bubna & family ₹6,200 Cr

About Sharda Cropchem Limited
Data last updated:
Sharda Cropchem Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 12 March 2004 and has been in existence for over 22 years.
Its director Ramprakash V Bubna and family are #544 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L51909MH2004PLC145007. Its GSTIN is 27AAICS0137P1ZZ (Maharashtra). The company holds 2 GST registrations, of which 1 is active. It is a listed company as per MCA records. Its shares are listed on BSE: 538666 and NSE: SHARDACROP.
The company has an authorised share capital of ₹105 Cr and a paid-up capital of ₹90.22 Cr. It was formerly known as Sharda Cropchem Private Limited and Sharda Worldwide Exports Private Limited. It is led by directors including Ramprakash Vilasrai Bubna (Managing Director) and Sharda Ramprakash Bubna (Whole-Time Director).
Its last annual general meeting (AGM) was held on 14 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 2nd Floor Prime Business Park, Mumbai, Maharashtra.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹5,446.47 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹653.12 Cr (net margin 12%) and EBITDA of ₹1,058.94 Cr (EBITDA margin 19.4%). The net worth stands at ₹3,136.49 Cr (up 25.4% YoY). Total assets are valued at ₹3,172.82 Cr (up 23.3% YoY).
The company has about 13 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 3 brands: Sharda Cropchem Limited, Sharda Africa and Sharda Crop Chem. As per MCA filings, the company has open charges of ₹455 Cr and satisfied charges of ₹75.74 Cr on record. Court records list 20 cases involving the company, including 7 filed by the company and 13 filed against it; 8 cases are pending. The company has 10 deals on record (8 market trades, 1 funding round, 1 ipo), with disclosed funding of ₹99.96 Cr; the latest was in July 2025. Its 4 peer companies in the Agriculture industry (Chemical Retail and Distribution, Pesticides), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 2 smaller; the largest is Hazel Mercantile Limited with revenue of ₹9,173.09 Cr. The company has 11 MSME Form 1 returns on record between 2018 and 2024, listing 233 overdue payments to 18 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shardacropchem.com.
Company details
Name history
Sharda Cropchem has undergone 2 name changes throughout its history. The company was previously known as Sharda Cropchem Private Limited, and Sharda Worldwide Exports Private Limited. The current legal name is Sharda Cropchem Limited.
| Company Name | Status |
|---|---|
| Sharda Cropchem Limited | Current |
| Sharda Cropchem Private Limited | Previous |
| Sharda Worldwide Exports Private Limited | Previous |
CIN history
Sharda Cropchem has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L51909MH2004PLC145007, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L51909MH2004PLC145007 | Current |
| U51909MH2004PTC145007 | Previous |
| U51909MH2004PLC145007 | Previous |
Recognitions & Rankings of Sharda Cropchem
Contact details
Sharda Cropchem Limited's registered office is in Mumbai, Maharashtra. Its website is shardacropchem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address2nd Floor Prime Business Park Dashrathlal Joshi Road Vile Parle (West, ), Mumbai, Maharashtra, India – 400056
- IndustryChemicals and Materials, Chemical Distribution & Retail
To see the full contact details of Sharda Cropchem Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Sharda Cropchem operates multiple associated brands including Sharda Cropchem Limited, Sharda Africa, and Sharda Crop Chem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pesticides, agrochemicals and other dye based products. | shardacropchem.com | |
| Cropchem services, agricultural supplies, and support in India. | shardaintl.com | |
| Agricultural chemicals and sustainable food production services in Africa. | shardaafrica.com |
Business activity
The main business activity of Sharda Cropchem is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sharda Cropchem Limited, buy the company report.
Financials of Sharda Cropchem Limited
FY 2025-26 filings availableSharda Cropchem Limited reported revenue of ₹5,446.47 Cr (up 23% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 5,446 | 4,427 | 3,271 | 4,045 | 3,580 | 2,396 | 2,003 |
| Revenue growth | +23.0% | +35.4% | -19.1% | +13.0% | +49.4% | +19.6% | - |
| EBITDA | 1,059 | 615 | 303 | 659 | 696 | 450 | 295 |
| EBITDA margin | +19.4% | +13.9% | +9.3% | +16.3% | +19.4% | +18.8% | +14.7% |
| Profit before tax | 856 | 378 | 71.88 | 431 | 464 | 309 | 185 |
| Net profit | 653 | 296 | 31.82 | 329 | 348 | 224 | 201 |
| Net profit margin | +12.0% | +6.7% | +1.0% | +8.1% | +9.7% | +9.4% | +10.0% |
| EPS (₹) | 75.47 | 33.74 | 3.53 | 37.90 | 38.71 | 25.40 | 18.25 |
| Balance sheet | |||||||
| Total assets | 3,173 | 2,573 | 2,316 | 2,240 | 1,966 | 1,704 | 1,421 |
| Net worth | 3,136 | 2,501 | 2,237 | 2,232 | 1,912 | 1,614 | 1,403 |
| Total debt | 0.00 | 7.76 | 18.30 | 2.96 | 46.65 | 80.76 | 0.09 |
| Cash & bank | 220 | 220 | 87.92 | 182 | 166 | 261 | 153 |
| Net working capital | 1,690 | 1,314 | 1,209 | 1,259 | 1,068 | 949 | 709 |
| Cash flow | |||||||
| Cash from operations | 656 | 604 | 341 | 328 | 267 | 246 | 146 |
| Cash from investing | (445) | (496) | (393) | (112) | (205) | (282) | (59.47) |
| Cash from financing | (118) | (67.93) | (36.91) | (97.10) | (90.96) | 43.35 | (59.73) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,074 | 2,065 | 1,289 | 929 | 985 | 1,829 | 929 | 777 |
| Revenue growth (YoY) | +9.0% | +12.9% | +38.7% | +19.6% | +25.4% | - | - | - |
| Other income | 34.53 | 22.45 | 21.24 | 29.37 | 32.49 | 25.23 | 0.62 | 25.48 |
| EBITDA | 186 | 487 | 241 | 133 | 215 | 303 | 115 | 89.62 |
| EBITDA margin | +17.3% | +23.6% | +18.7% | +14.3% | +21.9% | +16.6% | +12.3% | +11.5% |
| Depreciation | 100 | 86.96 | 83.30 | 76.18 | 78.08 | 71.90 | 68.89 | 69.10 |
| Interest | 1.81 | 0.47 | 0.39 | 0.34 | 0.56 | 0.41 | 0.45 | 0.48 |
| Profit before tax | 118 | 422 | 179 | 85.72 | 169 | 256 | 45.94 | 45.52 |
| Tax | 30.41 | 103 | 33.45 | 11.37 | 26.34 | 52.50 | 14.79 | 3.10 |
| Net profit | 88.02 | 319 | 145 | 74.35 | 143 | 204 | 31.15 | 42.42 |
| EPS (₹) | 9.76 | 35.32 | 16.09 | 8.24 | 15.83 | 22.57 | 3.45 | 4.70 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 4,716 | 3,753 | 2,693 | 3,313 | 2,946 | 2,033 | 1,616 |
| Revenue growth | +25.7% | +39.4% | -18.7% | +12.4% | +45.0% | +25.8% | - |
| EBITDA | 916 | 462 | 192 | 504 | 602 | 389 | 230 |
| EBITDA margin | +19.4% | +12.3% | +7.1% | +15.2% | +20.5% | +19.1% | +14.3% |
| Profit before tax | 844 | 343 | 175 | 411 | 392 | 285 | 209 |
| Net profit | 650 | 266 | 137 | 312 | 282 | 205 | 186 |
| Net profit margin | +13.8% | +7.1% | +5.1% | +9.4% | +9.6% | +10.1% | +11.5% |
| EPS (₹) | 75.07 | 30.34 | 15.16 | 35.99 | 31.36 | 23.25 | 21.27 |
| Balance sheet | |||||||
| Total assets | 2,936 | 2,402 | 2,186 | 2,006 | 1,784 | 1,592 | 1,329 |
| Net worth | 2,901 | 2,332 | 2,112 | 2,002 | 1,732 | 1,503 | 1,311 |
| Total debt | 0.00 | 7.76 | 14.92 | 0.00 | 46.65 | 80.76 | 0.00 |
| Cash & bank | 135 | 158 | 33.40 | 84.24 | 147 | 212 | 104 |
| Net working capital | 1,474 | 1,157 | 1,096 | 1,037 | 893 | 842 | 620 |
| Cash flow | |||||||
| Cash from operations | 576 | 475 | 163 | 140 | 277 | 202 | 52.99 |
| Cash from investing | (389) | (381) | (179) | (1.07) | (183) | (238) | 24.18 |
| Cash from financing | (117) | (62.24) | (34.96) | (98.10) | (90.37) | 44.13 | (59.58) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 969 | 1,871 | 1,121 | 814 | 825 | 1,614 | 800 | 590 |
| Revenue growth (YoY) | +17.5% | +15.9% | +40.2% | +38.0% | +25.5% | - | - | - |
| Other income | 107 | 92.07 | 70.58 | 46.15 | 31.88 | 65.30 | 81.12 | 12.73 |
| Total expenses | 797 | 1,426 | 908 | 729 | 639 | 1,379 | 726 | 528 |
| EBITDA | 172 | 445 | 213 | 84.40 | 186 | 235 | 73.98 | 61.48 |
| EBITDA margin | +17.7% | +23.8% | +19.0% | +10.4% | +22.6% | +14.6% | +9.3% | +10.4% |
| Depreciation | 100 | 86.91 | 83.26 | 76.14 | 78.04 | 71.88 | 68.88 | 69.08 |
| Interest | 1.32 | 0.03 | 0.07 | 0.10 | 0.14 | 0.18 | 0.22 | 0.25 |
| Profit before tax | 177 | 450 | 200 | 54.31 | 140 | 229 | 86.00 | 4.88 |
| Tax | 36.39 | 97.29 | 33.09 | 10.23 | 26.35 | 45.45 | 17.12 | 0.84 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,074 | 2,065 | 1,289 | 929 | 985 | 1,829 | 929 | 777 |
| Revenue growth (YoY) | +9.0% | +12.9% | +38.7% | +19.6% | +25.4% | - | - | - |
| Other income | 34.53 | 22.45 | 21.24 | 29.37 | 32.49 | 25.23 | 0.62 | 25.48 |
| EBITDA | 186 | 487 | 241 | 133 | 215 | 303 | 115 | 89.62 |
| EBITDA margin | +17.3% | +23.6% | +18.7% | +14.3% | +21.9% | +16.6% | +12.3% | +11.5% |
| Depreciation | 100 | 86.96 | 83.30 | 76.18 | 78.08 | 71.90 | 68.89 | 69.10 |
| Interest | 1.81 | 0.47 | 0.39 | 0.34 | 0.56 | 0.41 | 0.45 | 0.48 |
| Profit before tax | 118 | 422 | 179 | 85.72 | 169 | 256 | 45.94 | 45.52 |
| Tax | 30.41 | 103 | 33.45 | 11.37 | 26.34 | 52.50 | 14.79 | 3.10 |
| Net profit | 88.02 | 319 | 145 | 74.35 | 143 | 204 | 31.15 | 42.42 |
| EPS (₹) | 9.76 | 35.32 | 16.09 | 8.24 | 15.83 | 22.57 | 3.45 | 4.70 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 5,446 | 4,427 | 3,271 | 4,045 | 3,580 | 2,396 | 2,003 |
| Revenue growth | +23.0% | +35.4% | -19.1% | +13.0% | +49.4% | +19.6% | - |
| Other income | 142 | 59.53 | 59.76 | 40.28 | 28.88 | 45.94 | 43.11 |
| Total expenses | 4,388 | 3,813 | 2,968 | 3,386 | 2,884 | 1,945 | 1,708 |
| Employee cost | 66.69 | 52.02 | 42.43 | 44.80 | 44.17 | 37.32 | 34.90 |
| EBITDA | 1,059 | 615 | 303 | 659 | 696 | 450 | 295 |
| EBITDA margin | +19.4% | +13.9% | +9.3% | +16.3% | +19.4% | +18.8% | +14.7% |
| Depreciation | 325 | 275 | 267 | 248 | 245 | 170 | 137 |
| Interest | 21.16 | 21.49 | 24.19 | 20.17 | 15.01 | 16.22 | 16.01 |
| Profit before tax | 856 | 378 | 71.88 | 431 | 464 | 309 | 185 |
| Tax | 175 | 73.92 | 39.96 | 88.76 | 115 | 80.24 | 20.17 |
| Net profit | 653 | 296 | 31.82 | 329 | 348 | 224 | 201 |
| Net profit margin | +12.0% | +6.7% | +1.0% | +8.1% | +9.7% | +9.4% | +10.0% |
| EPS (₹) | 75.47 | 33.74 | 3.53 | 37.90 | 38.71 | 25.40 | 18.25 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 |
| Reserves & surplus | 3,046 | 2,410 | 2,147 | 2,142 | 1,822 | 1,524 | 1,313 |
| Shareholders' funds (net worth) | 3,136 | 2,501 | 2,237 | 2,232 | 1,912 | 1,614 | 1,403 |
| Minority interest | 0.55 | 0.41 | 0.38 | 0.35 | 0.33 | 0.31 | 0.26 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 38.04 | 67.85 | 0.00 |
| Unsecured loans | 0.00 | 7.76 | 18.30 | 2.96 | 8.61 | 12.91 | 0.09 |
| Total debt | 0.00 | 7.76 | 18.30 | 2.96 | 46.65 | 80.76 | 0.09 |
| Total liabilities | 3,173 | 2,573 | 2,316 | 2,240 | 1,966 | 1,704 | 1,421 |
| Assets | |||||||
| Gross block | 2,818 | 2,265 | 1,954 | 1,674 | 1,353 | 1,082 | 797 |
| Net block | 989 | 750 | 708 | 668 | 592 | 544 | 416 |
| Capital work in progress | 247 | 291 | 283 | 204 | 212 | 131 | 161 |
| Investments | 361 | 294 | 159 | 31.90 | 134 | 83.01 | 116 |
| Inventories | 1,120 | 972 | 992 | 1,134 | 893 | 526 | 382 |
| Sundry debtors | 2,389 | 1,955 | 1,498 | 1,833 | 1,540 | 1,163 | 989 |
| Cash & bank balances | 220 | 220 | 87.92 | 182 | 166 | 261 | 153 |
| Loans & advances | 348 | 144 | 201 | 76.75 | 118 | 67.67 | 40.87 |
| Total current assets | 4,077 | 3,292 | 2,779 | 3,226 | 2,717 | 2,016 | 1,565 |
| Total current liabilities | 2,386 | 1,978 | 1,570 | 1,968 | 1,649 | 1,067 | 856 |
| Net working capital | 1,690 | 1,314 | 1,209 | 1,259 | 1,068 | 949 | 709 |
| Total assets | 3,173 | 2,573 | 2,316 | 2,240 | 1,966 | 1,704 | 1,421 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 127 | 87.34 | 176 | 56.69 | 85.55 | 77.76 | 50.63 |
| Net cash from operating activities | 656 | 604 | 341 | 328 | 267 | 246 | 146 |
| Net cash from investing activities | (445) | (496) | (393) | (112) | (205) | (282) | (59.47) |
| Net cash from financing activities | (118) | (67.93) | (36.91) | (97.10) | (90.96) | 43.35 | (59.73) |
| Net change in cash | 92.61 | 39.87 | (89.02) | 120 | (28.86) | 7.79 | 27.12 |
| Closing cash | 220 | 220 | 87.92 | 182 | 166 | 261 | 153 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +23.0% | +35.4% | -19.1% | +13.0% | +49.4% | +19.6% | - |
| EBITDA growth | +72.2% | +102.7% | -53.9% | -5.3% | +54.5% | +52.7% | - |
| PBT growth | +126.1% | +426.3% | -83.3% | -7.2% | +50.0% | +67.4% | -21.4% |
| Net income growth | +120.4% | +831.4% | -90.3% | -5.4% | +55.3% | +11.5% | - |
| Revenue CAGR (3Y) | +10.4% | +7.3% | +10.9% | +26.4% | +21.5% | +12.0% | +12.7% |
| EBITDA CAGR (3Y) | +17.1% | -4.0% | -12.3% | +30.7% | +27.7% | +8.2% | -2.9% |
| Profitability & leverage | |||||||
| Net income margin | +12.5% | +6.9% | +1.0% | +8.5% | +9.8% | +9.6% | +8.2% |
| Return on capital employed | +30.5% | +16.4% | +4.2% | +21.5% | +26.1% | +20.9% | +18.3% |
| Return on net worth | +24.2% | +12.9% | +1.4% | +16.5% | +19.8% | +15.2% | +15.0% |
| Debt / equity | 0.00 | 0.01 | 0.00 | 0.01 | 0.04 | 0.03 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 2.88 | 6.32 | 66.62 | 4.91 | 3.33 | 5.80 | 10.15 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.14 | 2.10 | 1.80 | 2.67 | 2.94 | 2.55 | 2.82 |
| Inventory turnover | 5.21 | 4.51 | 3.08 | 3.99 | 5.05 | 5.28 | 5.36 |
| Debtors turnover | 2.51 | 2.56 | 1.96 | 2.40 | 2.65 | 2.23 | 2.23 |
| EPS (₹) | 75.47 | 33.74 | 3.53 | 37.90 | 38.71 | 25.40 | 18.25 |
| Dividend per share (₹) | 15.00 | 9.00 | 3.00 | 6.00 | 6.00 | 5.00 | 4.00 |
| Book value per share (₹) | 347.65 | 277.16 | 247.96 | 247.40 | 211.98 | 178.93 | 155.48 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 969 | 1,871 | 1,121 | 814 | 825 | 1,614 | 800 | 590 |
| Revenue growth (YoY) | +17.5% | +15.9% | +40.2% | +38.0% | +25.5% | - | - | - |
| Other income | 107 | 92.07 | 70.58 | 46.15 | 31.88 | 65.30 | 81.12 | 12.73 |
| Total expenses | 797 | 1,426 | 908 | 729 | 639 | 1,379 | 726 | 528 |
| EBITDA | 172 | 445 | 213 | 84.40 | 186 | 235 | 73.98 | 61.48 |
| EBITDA margin | +17.7% | +23.8% | +19.0% | +10.4% | +22.6% | +14.6% | +9.3% | +10.4% |
| Depreciation | 100 | 86.91 | 83.26 | 76.14 | 78.04 | 71.88 | 68.88 | 69.08 |
| Interest | 1.32 | 0.03 | 0.07 | 0.10 | 0.14 | 0.18 | 0.22 | 0.25 |
| Profit before tax | 177 | 450 | 200 | 54.31 | 140 | 229 | 86.00 | 4.88 |
| Tax | 36.39 | 97.29 | 33.09 | 10.23 | 26.35 | 45.45 | 17.12 | 0.84 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 4,716 | 3,753 | 2,693 | 3,313 | 2,946 | 2,033 | 1,616 |
| Revenue growth | +25.7% | +39.4% | -18.7% | +12.4% | +45.0% | +25.8% | - |
| Other income | 271 | 175 | 271 | 174 | 48.41 | 80.92 | 130 |
| Total expenses | 3,800 | 3,291 | 2,501 | 2,809 | 2,344 | 1,644 | 1,386 |
| Employee cost | 56.24 | 41.78 | 33.65 | 37.13 | 34.93 | 30.55 | 28.04 |
| EBITDA | 916 | 462 | 192 | 504 | 602 | 389 | 230 |
| EBITDA margin | +19.4% | +12.3% | +7.1% | +15.2% | +20.5% | +19.1% | +14.3% |
| Depreciation | 324 | 275 | 267 | 248 | 245 | 170 | 137 |
| Interest | 17.94 | 19.14 | 20.82 | 18.24 | 13.18 | 14.41 | 14.67 |
| Profit before tax | 844 | 343 | 175 | 411 | 392 | 285 | 209 |
| Tax | 167 | 69.11 | 38.28 | 86.56 | 110 | 74.89 | 16.92 |
| Net profit | 650 | 266 | 137 | 312 | 282 | 205 | 186 |
| Net profit margin | +13.8% | +7.1% | +5.1% | +9.4% | +9.6% | +10.1% | +11.5% |
| EPS (₹) | 75.07 | 30.34 | 15.16 | 35.99 | 31.36 | 23.25 | 21.27 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 | 90.22 |
| Reserves & surplus | 2,810 | 2,241 | 2,022 | 1,912 | 1,641 | 1,412 | 1,221 |
| Shareholders' funds (net worth) | 2,901 | 2,332 | 2,112 | 2,002 | 1,732 | 1,503 | 1,311 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 38.04 | 67.85 | 0.00 |
| Unsecured loans | 0.00 | 7.76 | 14.92 | 0.00 | 8.61 | 12.91 | 0.00 |
| Total debt | 0.00 | 7.76 | 14.92 | 0.00 | 46.65 | 80.76 | 0.00 |
| Total liabilities | 2,936 | 2,402 | 2,186 | 2,006 | 1,784 | 1,592 | 1,329 |
| Assets | |||||||
| Gross block | 2,794 | 2,242 | 1,931 | 1,674 | 1,352 | 1,081 | 796 |
| Net block | 988 | 750 | 708 | 668 | 592 | 544 | 416 |
| Capital work in progress | 247 | 291 | 283 | 204 | 212 | 131 | 161 |
| Investments | 368 | 295 | 160 | 33.02 | 136 | 84.16 | 117 |
| Inventories | 948 | 888 | 894 | 1,060 | 830 | 477 | 355 |
| Sundry debtors | 2,234 | 1,793 | 1,463 | 1,675 | 1,319 | 1,094 | 921 |
| Cash & bank balances | 135 | 158 | 33.40 | 84.24 | 147 | 212 | 104 |
| Loans & advances | 339 | 128 | 192 | 75.94 | 114 | 64.81 | 33.02 |
| Total current assets | 3,656 | 2,968 | 2,582 | 2,895 | 2,410 | 1,847 | 1,413 |
| Total current liabilities | 2,182 | 1,811 | 1,486 | 1,858 | 1,518 | 1,005 | 793 |
| Net working capital | 1,474 | 1,157 | 1,096 | 1,037 | 893 | 842 | 620 |
| Total assets | 2,936 | 2,402 | 2,186 | 2,006 | 1,784 | 1,592 | 1,329 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 64.47 | 32.82 | 83.93 | 42.92 | 38.77 | 30.21 | 12.61 |
| Net cash from operating activities | 576 | 475 | 163 | 140 | 277 | 202 | 52.99 |
| Net cash from investing activities | (389) | (381) | (179) | (1.07) | (183) | (238) | 24.18 |
| Net cash from financing activities | (117) | (62.24) | (34.96) | (98.10) | (90.37) | 44.13 | (59.58) |
| Net change in cash | 70.68 | 31.65 | (51.11) | 41.01 | 4.15 | 8.56 | 17.60 |
| Closing cash | 135 | 158 | 33.40 | 84.24 | 147 | 212 | 104 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +25.7% | +39.4% | -18.7% | +12.4% | +45.0% | +25.8% | - |
| EBITDA growth | +98.4% | +140.3% | -61.9% | -16.3% | +55.1% | +68.8% | - |
| PBT growth | +146.3% | +95.9% | -57.4% | +4.8% | +37.8% | +36.3% | -3.6% |
| Net income growth | +144.5% | +94.4% | -56.2% | +10.8% | +37.5% | +10.3% | - |
| Revenue CAGR (3Y) | +12.5% | +8.4% | +9.8% | +27.0% | +22.5% | +11.4% | +12.7% |
| EBITDA CAGR (3Y) | +22.0% | -8.5% | -20.9% | +29.9% | +29.4% | +4.5% | -6.2% |
| Profitability & leverage | |||||||
| Net income margin | +14.4% | +7.3% | +5.1% | +9.8% | +9.6% | +10.3% | +11.9% |
| Return on capital employed | +32.3% | +15.8% | +9.3% | +22.7% | +24.0% | +20.5% | +17.8% |
| Return on net worth | +25.9% | +12.3% | +6.7% | +17.4% | +17.5% | +14.9% | +15.5% |
| Debt / equity | 0.00 | 0.01 | 0.00 | 0.01 | 0.04 | 0.03 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 3.03 | 10.22 | -27.79 | 7.13 | 3.69 | 6.60 | 15.75 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.87 | 1.80 | 1.49 | 2.19 | 2.42 | 2.17 | 2.28 |
| Inventory turnover | 5.14 | 4.21 | 2.76 | 3.51 | 4.51 | 4.89 | 4.73 |
| Debtors turnover | 2.34 | 2.31 | 1.72 | 2.21 | 2.44 | 2.02 | 1.95 |
| EPS (₹) | 75.07 | 30.34 | 15.16 | 35.99 | 31.36 | 23.25 | 21.27 |
| Dividend per share (₹) | 15.00 | 9.00 | 3.00 | 6.00 | 6.00 | 5.00 | 4.00 |
| Book value per share (₹) | 321.49 | 258.42 | 234.07 | 221.93 | 191.93 | 166.56 | 145.30 |
To see the full year-wise statements and ratios of Sharda Cropchem Limited, buy the company report.
Board of directors of Sharda Cropchem Limited
Sharda Cropchem has 8 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonal Gunvant Desai | Director | 01 Apr 2019 | 7 Years 7 Months | Current |
| Ramprakash Vilasrai Bubna | Managing Director | 12 Mar 2004 | 22 Years 7 Months | Current |
| Sharda Ramprakash Bubna Also directs: Sharda Exports Private Limited | Whole-Time Director | 12 Mar 2004 | 22 Years 7 Months | Current |
| Manish Ramprakash Bubna | Whole-Time Director | 12 Mar 2004 | 22 Years 7 Months | Current |
| Ashish Ramprakash Bubna | Whole-Time Director | 12 Mar 2004 | 22 Years 7 Months | Current |
| Hosdurg Sundar Kamath Upendra Kamath | Director | 10 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Sharda Cropchem Limited is compared with the 4 companies closest to it by revenue in the Agriculture industry (Chemical Retail and Distribution, Pesticides), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hazel Mercantile Limited | ₹9,173.09 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Sharda Cropchem Limitedthis company | ₹5,446.47 Cr (FY 2026) | ₹653.12 Cr | 12% | 23.0% | 13 | Mumbai, Maharashtra, India |
| Sun International Limited | ₹5,122.19 Cr (FY 2024) | 11.0% | Kolkata, West Bengal, India | |||
| Veritas (India) Limited | ₹4,103.92 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Tegral India Private Limited | ₹3,591.82 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Sharda Cropchem Limited, buy the company report.
Auditor
Sharda Cropchem Limited is audited by BSR & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BSR & Associates LLP | FY 2023 | 116231W/W100024 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 74.80%, foreign institutional investors hold 3.10%, domestic institutional investors hold 9.20% and retail and other public shareholders hold 12.90%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 74.80% | 74.80% | 74.80% | 74.80% |
| Public | 25.20% | 25.20% | 25.20% | 25.20% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2011 | 10324025 | Others | ₹25 Cr | Open | |
| 21 Sep 2004 | 90145411 | Others | ₹430 Cr | Open | |
| 08 Mar 2018 | 100165286 | Others | ₹50 Cr | Satisfied | |
| 19 Jun 2008 | 10110139 | Standard Chartered Bank | ₹25.74 Cr | Satisfied |
To see the full charge records of Sharda Cropchem Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Sharda Cropchem Limited has 10 deals on record (8 market trades, 1 funding round, 1 ipo), with disclosed funding of ₹99.96 Cr; the latest was in July 2025.
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2025 | Market trade | ₹128.4 Cr | Buyer: Graviton Research Capital LLP , Hrti Private Limited Seller: Graviton Research Capital LLP , Hrti Private Limited |
| Jan 2022 | Market trade | ₹19.89 Cr | Buyer: XTX Markets LLP Seller: XTX Markets LLP |
| Jun 2018 | Market trade | ₹27.41 Cr | Seller: Goldman Sachs Public Market Fund |
| Sep 2014 | Market trade | ₹94.34 Cr | Buyer: Millennium Stock Broking Private Limited , Marwadi Shares and Finance Limited Seller: Millennium Stock Broking Private Limited , Marwadi Shares and Finance Limited |
| Sep 2014 | Market trade | ₹54.39 Cr | Buyer: Marwadi Shares and Finance Limited , Genuine Stock Brokers Private Limited , Vijeta Broking India Private Limited Seller: Marwadi Shares and Finance Limited , Genuine Stock Brokers Private Limited , Vijeta Broking India Private Limited |
To see the full deal history of Sharda Cropchem Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Sharda Cropchem Limited has 20 court cases on record: 7 filed by Sharda Cropchem, 13 filed against it. 8 cases are pending and 12 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 9 | 8 |
| District courts | 4 | 4 | 0 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Writ petition | Filed by the company against The Union of India | Pending |
| Bombay High Court | Writ petition | Filed by the company against The Centralized Processing Centre Income Tax Department Bengaluru | Pending |
| Bombay High Court | Tax appeal | Filed against the company by Commissioner of CGST and Central Excise | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| Bombay High Court | Tax appeal | Filed against the company by Pr.Commissioner of Income Tax-13,Mumbai | Pending |
To see the full case history of Sharda Cropchem Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Sharda Cropchem Limited was last rated by Crisil on 29 Apr 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 29 Apr 2020 |
To see the full credit ratings and regulatory alerts of Sharda Cropchem Limited, buy the company report.
MSME payment delays
Sharda Cropchem Limited has 11 MSME Form 1 returns on record between 2018 and 2024, listing 233 overdue payments to 18 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 18)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bioscience Research Foundation | |||
| Harmoni Analyticals Private Limited | |||
| Varanous Labs Private Limited | |||
| RCC Laboratories India Private Limited | |||
| Palamur Biosciences Private Limited |
To see the full MSME payment records of Sharda Cropchem Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sharda Cropchem has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Axis Crop Science Private Limited | U01100MH2009PTC189472 |
To see the full group structure of Sharda Cropchem Limited, buy the company report.
Employees & EPFO
Sharda Cropchem Limited has a workforce of 13 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
GST
Sharda Cropchem has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICS0137P1ZZ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sharda Cropchem Limited, buy the company report.
Recent activity
Sharda Cropchem Limited has 37 board changes on record since 2004: 23 appointments and 14 cessations. The latest: Shitin Dayalji Desai ceased to be Director on 08 Aug 2024.
36 earlier events are in the company report.
News
Frequently asked questions
Sharda Cropchem is an active public limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 12 March 2004 (22+ years old) and is registered under CIN L51909MH2004PLC145007. Listed on BSE: 538666 and NSE: SHARDACROP.
Sharda Cropchem reported revenue of ₹5,446.47 Cr for FY 2025-26 (up 23% YoY) based on consolidated financials.
Sharda Cropchem has 8 current directors:
- Ramprakash Vilasrai Bubna - Managing Director
- Sharda Ramprakash Bubna - Whole-Time Director
- Manish Ramprakash Bubna - Whole-Time Director
- Ashish Ramprakash Bubna - Whole-Time Director
- Sonal Gunvant Desai - Director
- Hosdurg Sundar Kamath Upendra Kamath - Director
- Vinod Kumar Kathuria - Director
- Shalin Sunandan Divatia - Director
The latest financial statements of Sharda Cropchem on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Sharda Cropchem is 27AAICS0137P1ZZ, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sharda Cropchem is L51909MH2004PLC145007. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Sharda Cropchem is a listed company as per MCA records. Its shares are listed on both BSE (code: 538666) and NSE (symbol: SHARDACROP).
Sharda Cropchem has 20 court cases on record: 7 filed by the company and 13 filed against it. 8 are pending. Most are in the high courts.
Sharda Cropchem was incorporated on 12 March 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
Sharda Cropchem has 10 deals on record (8 market trades, 1 funding round, 1 ipo), with disclosed funding of ₹99.96 Cr; the latest was in July 2025.
The peers of Sharda Cropchem by revenue are Hazel Mercantile Limited, Sun International Limited, Veritas (India) Limited, Tegral India Private Limited, all in the Agriculture industry (Chemical Retail and Distribution, Pesticides), with the same principal business activity (wholesale trading).
Shitin Dayalji Desai ceased to be Director on 08 Aug 2024. Shobhan Thakore ceased to be Director on 08 Aug 2024. Sundara Rajan Swaminathan Mittur ceased to be Director on 08 Aug 2024. Sharda Cropchem has 37 board changes on record in total.

